LIQUID FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A
US-2025161211-A1 · May 22, 2025 · US
Hanmi Pharmaceutical Co Ltd holds 5 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 5 |
| Recent patents | 5 |
| First publication | May 30, 2024 |
| Latest publication | May 22, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2025161211-A1 · May 22, 2025 · US
US-2025099558-A1 · Mar 27, 2025 · US
US-2024366609-A1 · Nov 7, 2024 · US
US-2024239895-A1 · Jul 18, 2024 · US
US-2024173329-A1 · May 30, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2025161211-A1 · May 22, 2025 · US
US-2025099558-A1 · Mar 27, 2025 · US
US-2024366609-A1 · Nov 7, 2024 · US
US-2024239895-A1 · Jul 18, 2024 · US
US-2024173329-A1 · May 30, 2024 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K31/519 | 3 |
| A61K45/06 | 3 |
| A61K2300/00 | 3 |
| C12Y302/01022 | 2 |
| A61K47/26 | 2 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 5 |
| Chemistry & Metallurgy | 4 |
Answers are generated from the same data shown on this page.